| Net loss | -11.1M |
| Depreciation | 602K |
| Amortization of intangible assets | 95K |
| Gain on disposal of property and equipment | |
| Non-cash stock-based compensation expense | 980K |
| Gain on derivative instruments, net | |
| Inventory write-downs | 187K |
| Non-cash deferred rent | |
| Accounts receivable, net | -134K |
| Costs and estimated earnings in excess of billings on uncompleted contracts | |
| Inventory | -577K |
| Other current assets | 177K |
| Other assets | |
| Accounts payable | -145K |
| Accrued liabilities | -303K |
| Billings in excess of costs and estimated earnings on uncompleted contracts | 0 |
| Other long-term liabilities | |
| Net cash used in operating activities | -10.86M |
| Sales of investment securities | |
| Purchases of restricted investment securities | |
| Decrease in restricted investment | |
| Proceeds on sale of property and equipment | |
| Purchases of property and equipment | -282K |
| Net cash used in investing activities | -282K |
| Principal payments under capital leases | |
| Principal payments under long-term debt | |
| Net proceeds from issuance of common stock | 9.06M |
| Net cash provided by financing activities | 9.06M |
| Net decrease in cash and cash equivalents | -2.09M |
| Cash and cash equivalents, at beginning of period | 7.89M |
| Cash and cash equivalents, at end of period | 5.8M |
| Cash paid for interest | |
| Other non-cash additions to property and equipment | 276K |
| Issuance of common stock for prepayment of salaries | |